COMMUNIQUÉS West-GlobeNewswire

Revolutionary Study at Ibogaine By David Dardashti Sheds Light on How Zodiac Signs Impact Treatment
14/03/2024
Quantum Physics and Astrology MIAMI, March 14, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to release the results of its lead researcher, Gavriel Dardashti's study analyzing the effects of astrological [...]
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
14/03/2024
Press Release Paris – March 14 th , 2024 – EUROAPI today announces that its Italian subsidiary, EUROAPI Italy S.R.L., is suspending the production of all APIs 1 in Brindisi. Following an internal audit, quality control [...]
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
14/03/2024
Communiqué de presse Paris – Le 14 mars 2024 – EUROAPI annonce aujourd’hui que sa filiale italienne EUROAPI Italy S.R.L. suspend la production de tous les APIs 1 sur son site de Brindisi. A la suite d’un audit interne, [...]
Fagron publishes annual report 2023
14/03/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 14 March 2024 – 6:30 PM CET Fagron publishes annual report 2023 Fagron, the leading global player in pharmaceutical compounding, today publishes its [...]
Annual General Meeting in ALK-Abelló A/S held on 14 March 2024
14/03/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): ALK-Abelló A/S held its Annual General Meeting on 14 March 2024. The Annual General Meeting transacted the following business: Approval of the annual report 2023 and discharge of [...]
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
14/03/2024
Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, researchers from the Mayo Clinic in Rochester (USA) and HepaRegeniX HRX-215 proved to be safe and well tolerated in [...]
IHA’s Symphony Chosen As Provider Directory Data Source for Covered California
14/03/2024
Symphony simplifies complex data exchange processes to ensure more accurate provider directory data for the state health insurance marketplace OAKLAND, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- The Integrated [...]
Sino Biological Announces Services Partnership with Rapid Novor
14/03/2024
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or [...]
SafeGuard Surgical Receives FDA "Breakthrough" Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston
14/03/2024
Tampa, FL, March 14, 2024 (GLOBE NEWSWIRE) -- SafeGuard Surgical , a leading medical technology company focused on life-saving biodegradable solutions, announced today a major milestone in its mission to improve global [...]
Rick Simpson Oil California Introduces RSO Suppositories A New Path to Wellness Through Direct Absorption
14/03/2024
Rick Simpson Oil California Offers New RSO Suppositories for a Natural, Effective Alternative for Diverse Health Conditions LOS ANGELES, March 14, 2024 (GLOBE NEWSWIRE) -- In expanding its natural health remedies, Rick [...]
Revolutionizing Chronic Kidney Disease Management on World Kidney Day
14/03/2024
LifeLabs Klinrisk Score Included in KDIGO 2024 CKD Guideline Toronto, March 14, 2024 (GLOBE NEWSWIRE) -- Today, as the world marks World Kidney Day, LifeLabs, in exclusive partnership with Klinrisk, proudly announces a [...]
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14/03/2024
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low [...]
Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit
14/03/2024
Presentation Will Discuss Cellular Immunotherapy’s Potential Role in Treating Chronic Conditions and Extending People’s Lives FLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“ [...]
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
14/03/2024
NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Astra Plastic Surgery adds double board-certified facial plastic surgeon to acclaimed roster
14/03/2024
Acclaimed plastic facial surgeon now practicing at Alpharetta and Cumming locations ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and reconstructive surgery [...]
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
14/03/2024
WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck ® combined with standard EKG or DPNCheck alone accurately [...]
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
14/03/2024
GRANTS, NEW MEXICO, March 14, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) Today announced that BGXX will install a 102-megawatt solar field to power the electricity [...]
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
14/03/2024
33% Response Rate and 100% Disease Control Rate Observed in Patients Evaluated for Efficacy Complete Response of Non-Target Tumor Also Observed Platinum-Resistant Ovarian Cancer is a Devastating Serious Condition of [...]
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
14/03/2024
First patient has been dosed in the randomized, controlled, double blind clinical trial for Autism Spectrum Disorder in pediatric patients TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC [...]

Pages